Veracyte, Inc.
VCYT
$28.61
-$0.46-1.58%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -113.91% | 37.83% | -66.26% | 164.30% | 407.62% |
| Total Depreciation and Amortization | 2.37% | -14.25% | 6.38% | 2.44% | 2.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 234.25% | -51.96% | 92.42% | -26.66% | 21.31% |
| Change in Net Operating Assets | 107.97% | -266.31% | -4,515.38% | -101.57% | 125.42% |
| Cash from Operations | 526.73% | -78.14% | -18.15% | 1.31% | 429.86% |
| Capital Expenditure | 29.30% | 56.07% | -84.70% | 19.06% | -29.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 102.12% | 0.00% | -- | -- | -- |
| Cash from Investing | 99.57% | 4.29% | -2,314.85% | 19.06% | -196.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -38.86% | -9.10% | -73.82% | 865.09% | -56.47% |
| Repurchase of Common Stock | 74.82% | -188.67% | -50.18% | -67.31% | 66.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 91.27% | -43.77% | -143.83% | 93,636.36% | 98.73% |
| Foreign Exchange rate Adjustments | 674.32% | 118.45% | -374.66% | 339.34% | 43.52% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 163.16% | -53.11% | -190.49% | 42.73% | 478.65% |